An approach for the transition from systemic immunosuppressants to dupilumab
Gespeichert in:
| Veröffentlicht in: | Journal of the European Academy of Dermatology and Venereology 2021-03, Vol.35 (3), p.e221-e223 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e223 |
|---|---|
| container_issue | 3 |
| container_start_page | e221 |
| container_title | Journal of the European Academy of Dermatology and Venereology |
| container_volume | 35 |
| creator | Wijs, L.E.M. Thyssen, J.P. Vestergaard, C. Thio, H.B. Kunkeler, A.C.M. Biedermann, T. Hijnen, D.J. |
| description | |
| doi_str_mv | 10.1111/jdv.16941 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2442598525</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2442598525</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3601-c12396c4a9d828dec7d80b2485576eb8d49dc261f4ae4a635d70b69a748dc1a13</originalsourceid><addsrcrecordid>eNp1kLtOwzAUQC0EoqUw8APIIwyhfsceq_JWJRZgjRzbUV3FSbETUP-eQAobd7nLuUdXB4BzjK7xMPON_bjGQjF8AKaYCZlRJOkhmCJFRKYUVxNwktIGIYQxl8dgQokiSFEyBatFA_V2G1tt1rBqI-zWDnZRN8l3vm1gFdsA0y51LngDfQh906Z-OHAp6aZLsGuh7be-7oMuT8FRpevkzvZ7Bl7vbl-WD9nq-f5xuVhlhgqEM4MJVcIwrawk0jqTW4lKwiTnuXCltExZQwSumHZMC8ptjkqhdM6kNVhjOgOXo3f4-713qSuCT8bVtW5c26eCMEa4kpzwAb0aURPblKKrim30QcddgVHxHa8Y4hU_8Qb2Yq_ty-DsH_lbawDmI_Dpa7f731Q83byNyi9sG3mZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2442598525</pqid></control><display><type>article</type><title>An approach for the transition from systemic immunosuppressants to dupilumab</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Wijs, L.E.M. ; Thyssen, J.P. ; Vestergaard, C. ; Thio, H.B. ; Kunkeler, A.C.M. ; Biedermann, T. ; Hijnen, D.J.</creator><creatorcontrib>Wijs, L.E.M. ; Thyssen, J.P. ; Vestergaard, C. ; Thio, H.B. ; Kunkeler, A.C.M. ; Biedermann, T. ; Hijnen, D.J.</creatorcontrib><identifier>ISSN: 0926-9959</identifier><identifier>EISSN: 1468-3083</identifier><identifier>DOI: 10.1111/jdv.16941</identifier><identifier>PMID: 32920932</identifier><language>eng</language><publisher>England</publisher><subject>Antibodies, Monoclonal, Humanized ; Dermatitis, Atopic - drug therapy ; Humans ; Immunosuppressive Agents</subject><ispartof>Journal of the European Academy of Dermatology and Venereology, 2021-03, Vol.35 (3), p.e221-e223</ispartof><rights>2020 European Academy of Dermatology and Venereology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3601-c12396c4a9d828dec7d80b2485576eb8d49dc261f4ae4a635d70b69a748dc1a13</citedby><cites>FETCH-LOGICAL-c3601-c12396c4a9d828dec7d80b2485576eb8d49dc261f4ae4a635d70b69a748dc1a13</cites><orcidid>0000-0001-5095-4281 ; 0000-0003-3770-1743 ; 0000-0001-6801-0828 ; 0000-0003-3379-3425 ; 0000-0001-6485-3158</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjdv.16941$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjdv.16941$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32920932$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wijs, L.E.M.</creatorcontrib><creatorcontrib>Thyssen, J.P.</creatorcontrib><creatorcontrib>Vestergaard, C.</creatorcontrib><creatorcontrib>Thio, H.B.</creatorcontrib><creatorcontrib>Kunkeler, A.C.M.</creatorcontrib><creatorcontrib>Biedermann, T.</creatorcontrib><creatorcontrib>Hijnen, D.J.</creatorcontrib><title>An approach for the transition from systemic immunosuppressants to dupilumab</title><title>Journal of the European Academy of Dermatology and Venereology</title><addtitle>J Eur Acad Dermatol Venereol</addtitle><subject>Antibodies, Monoclonal, Humanized</subject><subject>Dermatitis, Atopic - drug therapy</subject><subject>Humans</subject><subject>Immunosuppressive Agents</subject><issn>0926-9959</issn><issn>1468-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kLtOwzAUQC0EoqUw8APIIwyhfsceq_JWJRZgjRzbUV3FSbETUP-eQAobd7nLuUdXB4BzjK7xMPON_bjGQjF8AKaYCZlRJOkhmCJFRKYUVxNwktIGIYQxl8dgQokiSFEyBatFA_V2G1tt1rBqI-zWDnZRN8l3vm1gFdsA0y51LngDfQh906Z-OHAp6aZLsGuh7be-7oMuT8FRpevkzvZ7Bl7vbl-WD9nq-f5xuVhlhgqEM4MJVcIwrawk0jqTW4lKwiTnuXCltExZQwSumHZMC8ptjkqhdM6kNVhjOgOXo3f4-713qSuCT8bVtW5c26eCMEa4kpzwAb0aURPblKKrim30QcddgVHxHa8Y4hU_8Qb2Yq_ty-DsH_lbawDmI_Dpa7f731Q83byNyi9sG3mZ</recordid><startdate>202103</startdate><enddate>202103</enddate><creator>Wijs, L.E.M.</creator><creator>Thyssen, J.P.</creator><creator>Vestergaard, C.</creator><creator>Thio, H.B.</creator><creator>Kunkeler, A.C.M.</creator><creator>Biedermann, T.</creator><creator>Hijnen, D.J.</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5095-4281</orcidid><orcidid>https://orcid.org/0000-0003-3770-1743</orcidid><orcidid>https://orcid.org/0000-0001-6801-0828</orcidid><orcidid>https://orcid.org/0000-0003-3379-3425</orcidid><orcidid>https://orcid.org/0000-0001-6485-3158</orcidid></search><sort><creationdate>202103</creationdate><title>An approach for the transition from systemic immunosuppressants to dupilumab</title><author>Wijs, L.E.M. ; Thyssen, J.P. ; Vestergaard, C. ; Thio, H.B. ; Kunkeler, A.C.M. ; Biedermann, T. ; Hijnen, D.J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3601-c12396c4a9d828dec7d80b2485576eb8d49dc261f4ae4a635d70b69a748dc1a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibodies, Monoclonal, Humanized</topic><topic>Dermatitis, Atopic - drug therapy</topic><topic>Humans</topic><topic>Immunosuppressive Agents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wijs, L.E.M.</creatorcontrib><creatorcontrib>Thyssen, J.P.</creatorcontrib><creatorcontrib>Vestergaard, C.</creatorcontrib><creatorcontrib>Thio, H.B.</creatorcontrib><creatorcontrib>Kunkeler, A.C.M.</creatorcontrib><creatorcontrib>Biedermann, T.</creatorcontrib><creatorcontrib>Hijnen, D.J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wijs, L.E.M.</au><au>Thyssen, J.P.</au><au>Vestergaard, C.</au><au>Thio, H.B.</au><au>Kunkeler, A.C.M.</au><au>Biedermann, T.</au><au>Hijnen, D.J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An approach for the transition from systemic immunosuppressants to dupilumab</atitle><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle><addtitle>J Eur Acad Dermatol Venereol</addtitle><date>2021-03</date><risdate>2021</risdate><volume>35</volume><issue>3</issue><spage>e221</spage><epage>e223</epage><pages>e221-e223</pages><issn>0926-9959</issn><eissn>1468-3083</eissn><cop>England</cop><pmid>32920932</pmid><doi>10.1111/jdv.16941</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-5095-4281</orcidid><orcidid>https://orcid.org/0000-0003-3770-1743</orcidid><orcidid>https://orcid.org/0000-0001-6801-0828</orcidid><orcidid>https://orcid.org/0000-0003-3379-3425</orcidid><orcidid>https://orcid.org/0000-0001-6485-3158</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0926-9959 |
| ispartof | Journal of the European Academy of Dermatology and Venereology, 2021-03, Vol.35 (3), p.e221-e223 |
| issn | 0926-9959 1468-3083 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2442598525 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Antibodies, Monoclonal, Humanized Dermatitis, Atopic - drug therapy Humans Immunosuppressive Agents |
| title | An approach for the transition from systemic immunosuppressants to dupilumab |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T23%3A40%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20approach%20for%20the%20transition%20from%20systemic%20immunosuppressants%20to%20dupilumab&rft.jtitle=Journal%20of%20the%20European%20Academy%20of%20Dermatology%20and%20Venereology&rft.au=Wijs,%20L.E.M.&rft.date=2021-03&rft.volume=35&rft.issue=3&rft.spage=e221&rft.epage=e223&rft.pages=e221-e223&rft.issn=0926-9959&rft.eissn=1468-3083&rft_id=info:doi/10.1111/jdv.16941&rft_dat=%3Cproquest_cross%3E2442598525%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2442598525&rft_id=info:pmid/32920932&rfr_iscdi=true |